Stock Comparison

BNTX vs REGN

BioNTech SE and Regeneron Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.

BNTX

BioNTech SE

Healthcare

REGN

Regeneron Pharmaceuticals Inc

Healthcare

Valuation

Market Cap

$23.07B

$66.35B

P/E (TTM)

—

15.5

Forward P/E

7.0

14.1

Price/Sales

8.2

4.5

Price/Book

1.0

2.1

EV/EBITDA

32.7

10.5

Dividend Yield

—

0.58%

Profitability

Net Margin

-44.60%

29.60%

Operating Margin

-577.00%

20.70%

Return on Equity

-6.66%

14.50%

Return on Assets

-4.18%

6.13%

Growth (YoY)

Revenue Growth

-35.40%

19.00%

Earnings Growth

-43.20%

-7.20%

Price & Risk

Beta

1.3

0.2

52-Week High

$124.00

$818.90

52-Week Low

$79.52

$516.07

Analyst Target

$121.59

$833.31

Compare BNTX and REGN your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.